• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. LAGB SYSTEM 10CM; ADJUSTABLE GASTRIC BAND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. LAGB SYSTEM 10CM; ADJUSTABLE GASTRIC BAND Back to Search Results
Model Number B-20220
Device Problem Fluid/Blood Leak (1250)
Patient Problems Adhesion(s) (1695); Weight Changes (2607)
Event Type  malfunction  
Manufacturer Narrative
Unknown taper.Medwatch sent to fda 02/23/2017.The reporter of the event was asked to return the product for analysis.To date, apollo has not received the device.If returned, visual examination may confirm or determine another taper type associated with this event.Precautions: care must be taken during band adjustment to avoid puncturing the tubing that connects the access port and band, as this will cause leakage and deflation of the inflatable section.Failure to create a stable, smooth path for the access port tubing, without sharp turns or bends, can result in tubing breaks and leakage.In order to avoid incorrect placement, the port should be placed lateral to the trocar opening.A pocket must be created for the port so that it is placed far enough from the trocar path to avoid abrupt kinking of the tubing.The tubing path should point in the direction of the access port connector so that the tubing will form a straight line with a gentle arching transition into the abdomen.When adjusting band volume, the needle must be inserted perpendicular to the access port septum.Failure to do so may cause damage to the port and result in leaks.Adverse events: it is important to discuss all possible complications and adverse events with your patient.Complications which may result from the use of this product include the risks associated with the medications and methods utilized in the surgical procedure, the risks associated with any surgical procedure and the patient's degree of intolerance to any foreign object implanted in the body.Ulceration, gastritis, gastroesophageal reflux, heartburn, gas bloat, dysphagia, dehydration, constipation, and weight regain have been reported after gastric restriction procedures.Gastric banding done as a revision procedure has a greater risk of complications.Prior abdominal surgery is commonly associated with adhesions involving the stomach.In the us pivotal study of severely obese adults, 42% of the subjects undergoing revision surgery were reported to have adhesions involving the stomach.Care and time must be taken to adequately release the adhesions to provide access, exposure and mobilization of the stomach for a revision procedure.Unplanned deflation of the band may occur due to leakage from the band, the port or the connecting tubing.
 
Event Description
Reported as: a patient had the entire lap-band system removed on (b)(6) 2016 due to "kink in the tubing." explanting physician had noted, "band was not holding fills, there was no fluid within the band, indicating fluid was leaking from the band itself." patient also had "recent weight gain".The lap-band system was originally implanted on (b)(6) 2006.The patient had a port revision and replacement surgery on (b)(6) 2012 due to "break in the tubing at the level where the tubing was coming into the abdominal wall, the tube was cracked completely and there was an obvious leak".Per op report, during the surgery on (b)(6) 2012, the explanting physician noted "removing the scar tissue".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAGB SYSTEM 10CM
Type of Device
ADJUSTABLE GASTRIC BAND
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capitol of texas hwy
bldg 1, ste 300
austin TX 78746
Manufacturer (Section G)
ALLERGAN
global park free zone
900 global park
la aurora de heredia
Manufacturer Contact
laura leboeuf
1120 s capital of texas hwy
bldg 1, ste 300
austin, TX 78746
5122795141
MDR Report Key6355168
MDR Text Key68225257
Report Number3006722112-2017-00051
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
PMA/PMN Number
P000008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial
Report Date 01/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Model NumberB-20220
Device Catalogue NumberB-20220
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/26/2017
Initial Date FDA Received02/23/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AMBIEN; BUPROPION HCI XL; DICLOFENAC ER; ESCITALOPRAM; LEXAPRO; LOVASTATIN; LOVOTHYROXINE; VOLTAREN; WELLBUTRIN; ZOLPIDEM
Patient Outcome(s) Required Intervention;
Patient Age56 YR
Patient Weight64
-
-